An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Some experts said the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.
Platform Reaction and Content Elimination
Based on the social media company, the platform has taken down problematic material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for mixing or injecting at home.
After moments of joining one community, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Within these communities, posts show dark colored parcels with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service said it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has already encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to potentially significant medical dangers”.
